Since we have previously reported an effect of the APOE genotype on IAPP-autoantibody levels in AD patients, we also investigated if plasma IAPPO-IgA levels in T2D patients are dependent on APOE4 status. The gene discussed is CD79A; the disease is Alzheimer disease.